查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363922

全球沙門氏菌檢測與治療市場 2023-2030

Global Salmonella Testing and Treatment Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030年），全球沙門氏菌檢測和治療市場將以 7.5% 的年複合成長率成長。沙門氏菌是一種影響腸道的細菌性疾病。沙門氏菌通常生活在動物和人類腸道中，並透過糞便排出。人類最常透過受污染的水或食物而被感染。食物感染患者數量的增加是支持市場成長的主要因素。據農業環境和農村事務部稱，已知沙門氏菌菌株（血清型）超過 2,500 種，其中大多數很少引起疾病。

此外，某些菌株，例如腸炎沙門氏菌和鼠傷寒沙門氏菌，可能會引起人類疾病。因此，人們和政府預防沙門氏菌感染的意識不斷增強，是推動全球沙門氏菌檢測和治療市場的另一個因素。例如，2003年12月，議會和理事會關於控制沙門氏菌的條例，確保採取適當和有效的措施，在生產、加工和分銷的所有相關階段檢測和控制沙門氏菌和其他人畜共患病病原體，以減少其流行率以及它們對公共健康構成的風險。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Abbott
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Eiken Chemical Co., Ltd.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • GlaxoSmithKline
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按測試方法分類的全球沙門氏菌測試和治療市場
    • 基於文化的方法
    • 基於分子的方法
    • 免疫測定
  • 按樣本類型分類的全球沙門氏菌檢測和治療市場
    • 食物
    • 水
    • 環境表面
  • 全球沙門氏菌檢測與治療市場（按應用）
    • 臨床診斷
    • 食品安全檢測
    • 獸醫診斷

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • 3M Co.
  • Becton, Dickinson, and Company
  • Biomerieux
  • Bio-Rad Laboratories, Inc.
  • Enzo Life Sciences, Inc.
  • Hardy Diagnostics
  • IDEXX Laboratories, Inc.
  • Merck KGaA
  • Mylab Discovery Solutions Pvt. Ltd.
  • PerkinElmer Inc.
  • Shimadzu Diagnostics Corp.
  • Thermo Fisher Scientific Inc.
Product Code: OMR2027707

Title: Global Salmonella Testing and Treatment Market Size, Share & Trends Analysis Report by Testing Method (Culture-based Methods, Molecular-based Methods, and Immunoassays), by Sample Type (Food, Water, and Environmental Surfaces), and by Application (Clinical Diagnostics, Food Safety Testing, and Veterinary Diagnostics)Forecast Period (2023-2030).

The global salmonella testing and treatment market is anticipated to grow at a CAGR of 7.5% during the forecast period (2023-2030). Salmonella is a bacterial disease that affects the intestinal tract. Salmonella bacteria typically live in animal and human intestines and are shed through stool (feces). Humans become infected most frequently through polluted water or food. The increasing number of patients suffering from food infection is the primary factor supporting the market growth. According to the Department of Agriculture, Environment and Rural Affairs, over 2,500 strains (serovars) of Salmonella are known most of which rarely cause disease.

Furthermore, certain strains, such as salmonella enteritidis and salmonella typhimurium, may cause human disease. Hence, the increasing awareness among people and government initiatives for the prevention of salmonella infection is another factor driving the salmonella testing and treatment market globally. For instance, in December 2003, Parliament and Council Regulation on the control of salmonella to ensure that proper and effective measures were taken to detect and control Salmonella and other zoonotic agents at all relevant stages of production, processing, and distribution, to reduce their prevalence and the risk they pose to public health.

Segmental Outlook

The global salmonella testing and treatment market is segmented on the testing method, sample type, and application. Based on the testing method, the market is sub-segmented into culture-based Methods, molecular-based Methods, and immunoassays. Based on sample type, the market is sub-segmented into food, water, and environmental surfaces. Further, based on application, the market is sub-segmented into clinical diagnostics, food safety testing, and veterinary diagnostics.

The Molecular-Based Methods Sub-Segment is Anticipated to Hold a Considerable Share of the Global Salmonella Testing and Treatment Market

Among the industry verticals, the molecular-based method sub-segment is expected to hold a considerable share of the global salmonella testing and treatment market. The segmental growth is attributed to the adoption of testing methods such as polymerase chain reaction (PCR), DNA, loop-mediated isothermal amplification (LAMP), Nucleic acid sequence-based amplification (NASBA), recombinase polymerase amplification (RPA) and whole-genome sequencing. For Instance, in March 2012, Abbott collaborated with Genetics Laboratory, Inc. (GenLab) on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections. Under the terms of the agreement, Abbott, in conjunction with GenLab, will develop and commercialize the new assay for use on the PLEX-ID™ automated microbial identification system.

Regional Outlook

The global salmonella testing and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, European Union has specific regulations in place for Salmonella testing in various food categories, such as poultry and eggs, and also has a focus on food safety and implements strict regulations for ensuring the quality of food products.

The North America Region is Expected to Grow at a Significant CAGR in the Global Salmonella Testing and Treatment Market

Among all regions, the North America region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to a high prevalence of food-borne illnesses in North America. According to the Centers for Disease Control and Prevention (CDC), the US estimates that Salmonella is responsible for 1.4 million infections, 26,500 hospitalizations, and 420 fatalities. With the creation of the Interagency Food Safety Analytics Collaboration (IFSAC) in 2011; CDC, the U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture's Food Safety and Inspection Service (USDA-FSIS) agreed to improve data and methods used to estimate foodborne illness source attribution and provide timely estimates of the food sources of four priority foodborne pathogens: Salmonella, Escherichia coli O157, Listeria monocytogenes and Campylobacter.

Market Players Outlook

The major companies serving the salmonella testing and treatment market include Abbott, Eiken Chemical Co., Ltd., GlaxoSmithKline, 3M, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2017, Merck KGaA acquired Biocontrol to Strengthen its Position in food safety testing the global spotlight on the importance of food safety has grown given the increased incidents of outbreaks and recalls with foodborne diseases often caused by consuming a wide range of foods including undercooked meat, eggs, fresh produce and dairy products contaminated by Salmonella, Listeria, E. coli O157H7 and Campylobacter.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global salmonella testing and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Eiken Chemical Co., Ltd.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. GlaxoSmithKline
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Salmonella Testing and treatment Market by Testing Method
    • 4.1.1. Culture-Based Methods
    • 4.1.2. Molecular-Based Methods
    • 4.1.3. Immunoassays
  • 4.2. Global Salmonella Testing and treatment Market by Sample Type
    • 4.2.1. Food
    • 4.2.2. Water
    • 4.2.3. Environmental Surfaces
  • 4.3. Global Salmonella Testing and treatment Market by Application
    • 4.3.1. Clinical Diagnostics
    • 4.3.2. Food Safety Testing
    • 4.3.3. Veterinary Diagnostics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 3M Co.
  • 6.2. Becton, Dickinson, and Company
  • 6.3. Biomerieux
  • 6.4. Bio-Rad Laboratories, Inc.
  • 6.5. Enzo Life Sciences, Inc.
  • 6.6. Hardy Diagnostics
  • 6.7. IDEXX Laboratories, Inc.
  • 6.8. Merck KGaA
  • 6.9. Mylab Discovery Solutions Pvt. Ltd.
  • 6.10. PerkinElmer Inc.
  • 6.11. Shimadzu Diagnostics Corp.
  • 6.12. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 2. GLOBAL CULTURE-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL IMMUNOASSAYS FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 6. GLOBAL SALMONELLA TESTING AND TREATMENT ON FOOD MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SALMONELLA TESTING AND TREATMENT ON WATER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SALMONELLA TESTING AND TREATMENT ON ENVIRONMENTAL SURFACES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SALMONELLA CLINICAL DIAGNOSTICS TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL SALMONELLA FOOD SAFTY TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SALMONELLA VETERINARY DIAGNOSTICS TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 20. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY TESTING MODE, 2022 VS 2030 (%)
  • 2. GLOBAL CULTURE-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY SAMPLE TYPE, 2022 VS 2030 ($ MILLION)
  • 6. GLOBAL SALMONELLA TESTING AND TREATMENT ON FOOD MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SALMONELLA TESTING AND TREATMENT ON WATER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SALMONELLA TESTING AND TREATMENT ON ENVIRONMENTAL SURFACES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SALMONELLA CLINICAL DIAGNOSTICS TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL SALMONELLA FOOD SAFTY TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SALMONELLA VETERINARY DIAGNOSTICS TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)